#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic cutaneous lupus erythematosus Immune-mediated myositis Idiopathic inflammatory myopathy Immunodeficiency congenital Vascular malformation Transplant rejection Anal fistula Acute graft versus host disease in intestine Endometrial adenocarcinoma Rhabdomyosarcoma recurrent B-cell small lymphocytic lymphoma refractory Vulval cancer VEXAS syndrome Myeloid leukaemia Familial amyotrophic lateral sclerosis More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer Leukoencephalopathy – Life with Disease Pulmonary fibrosis – Life with Disease Factor VIII deficiency Angiosarcoma Sjogren’s syndrome – Trials in Disease Haemophilia B without inhibitors – Life with Disease Progressive supranuclear palsy – Diagnostics Mantle cell lymphoma refractory – Basic Information Bronchopulmonary dysplasia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tadalafil Calcium Lactate Gluconate Ganciclovir Sodium Ephedrine Hydrochloride Etrumadenant Dexamethasone Acetate Mps-102 Candesartan Alizapride Sodium Iodide Gindameran Lovotibeglogene Autotemcel Azd5492 Brinzolamide Gen1055 Medroxyprogesterone Acetate RNMB3 Narsoplimab INOBRODIB Palivizumab More therapies…

    Learn about Your Condition

    Nocturia Pulmonary congestion Insomnia Obstructive airways disorder Fibromyalgia Acarodermatitis Vulval cancer recurrent Perinatal depression Wheezing Breast cancer stage I Notalgia paraesthetica Malabsorption Rectal cancer Epilepsy Intestinal ischaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Obesity

  • Study on Bupropion Hydrochloride and Naltrexone Hydrochloride for Patients with Weight Regain After Bariatric Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic surgery
    • Obesity
    Investigated Drugs:
    • Naltrexone Hydrochloride
    • Bupropion Hydrochloride
    The Netherlands

  • Study of semaglutide and pramlintide combination therapy for people with obesity and prediabetes

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Pramlintide Acetate
    • Paracetamol
    • Semaglutide
    Denmark

  • Study on the Safety and Effects of AZD9550 for Overweight and Obese Patients with Non-Alcoholic Steatohepatitis (NASH) with or without Type 2 Diabetes

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • AZD6234
    • Azd9550
    • Calcium
    Austria Germany Sweden

  • A study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • Orlistat (EMP22) and Drug Combination (acarbose + orlistat) in Healthy Volunteers with Obesity

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • ACARBOSE
    • Orlistat
    Sweden

  • A study testing maridebart cafraglutide for weight loss in adults with overweight or obesity, with or without type 2 diabetes

    Not recruiting

    2 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Maridebart Cafraglutide
    Czechia Germany Hungary Poland Spain
Previous Page
1 … 7 8 9 10 11 … 18
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!